Terfenadine off the market

February 1997

    The FDA is trying to take terfenadine off the market...Seldane, Seldane-D, and the new generics from Rugby and Zenith.

    There have been hundreds of reports of arrhythmias and sudden death associated with terfenadine. The FDA says it's no longer worth the risk...now that Allegra is on the market.

    Allegra (fexofenadine) is the active metabolite of terfenadine...it's just as effective, but without the risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote